Healthcare101

 The gene therapy market is expected to reach USD 36.55 billion by 2032 from USD 8.85 billion in 2024, at a CAGR of 19.4% during the forecast period. Growth in the gene therapy market is mainly driven by factors such as increasing regulatory approvals for gene therapy products, increasing investments in gene therapy research, and technological advancements. However, the high cost of gene therapy products is expected to restrain the market growth to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857962 Based on therapy type, the gene therapy market is segmented into gene silencing therapy, cell replacement therapy, gene augmentation therapy and other therapies. The gene silencing therapy segment accounted for the largest share of the gene therapy market. This can be owing to the availability of many approved and commercialized gene therapies employing gene silencing mechanism of action in the current market, effectiveness of gen...

 The Latin America ostomy dressings market is projected to reach USD 0.40 billion by 2030 from USD 0.30 billion in 2025, at a CAGR of 6.4% during the forecast period. Market growth is driven by several key factors, including the rising incidence of colorectal and bladder cancers, the increasing prevalence of inflammatory bowel diseases, and a rapidly aging population that requires long-term ostomy care. Additionally, improvements in public healthcare coverage and greater accessibility to surgical procedures have led to an increase in the number of ostomies performed across various regions. Furthermore, there is a growing trend toward home care and patient education, along with enhanced availability of new skin barrier and pouching systems, all of which contribute to the increased use of these products. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200293770 KEY TAKEAWAYS Based on country, Brazil accounted for the largest share of 32.5% of the Latin ...

 The Trauma Simulation market , valued at US$0.45 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$0.73 billion by the end of the period. The trauma simulation market is growing, fueled by the increasing use of high-fidelity patient simulators, immersive VR/AR platforms, and AI-driven scenarios that enable realistic physiological modeling, adaptive case progression, and collaborative trauma training. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48992606 The trauma simulation market continues to expand as healthcare providers increasingly invest in realistic simulation and technology-enabled training to improve outcomes in emergency and trauma care. Around 1.19 million people lose their lives on roads globally each year (Source: US CDC). According to the WHO, nearly 5 million people die due to injuries (road traffic crashes, burns,...

 The global Foley Catheters Market , valued at US$895.0 million in 2024, stood at US$931.0 million in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2030, culminating in a forecasted valuation of US$1,205.0 million by the end of the period. This growth is driven by several factors, including the increasing prevalence of urinary incontinence, kidney and bladder disorders, and prostate-related conditions, particularly among the aging population. Additionally, the rise in surgical procedures performed in hospitals and ambulatory surgical centers is contributing to consistent demand for Foley catheters, as they are commonly used for perioperative care and post-surgical recovery. Furthermore, the expansion of healthcare access in emerging economies is creating new opportunities for market growth. Technological advancements, such as antimicrobial coatings and infection-prevention designs, are also encouraging the preference for higher-quality products. Together...

 The global Knee Replacement Surgery Market , valued at US$10.86 billion in 2023 stood at US$12.00 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$16.17 billion by the end of the period. The key factor propelling the market is the increasing prevalence of osteoarthritis, particularly among the aging population. This increase in cases is driving a higher demand for surgical interventions, including total and partial knee replacements. As life expectancy increases and age-associated degenerative changes to the knee joint become more pronounced, the necessity for these procedures is escalating. This demographic shift is a significant catalyst for market expansion, contributing to a growing global patient population requiring knee treatment solutions. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=246869535 The orthobiologics segment is expected to register a significa...

 The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population. The demand for safe and reliable devices is driven by the growing use of IV therapy across hospitals, clinics, and home care settings. The introduction of needle-free connectors and smart infusion systems, together with advancements in the healthcare infrastructure in developing countries, is contributing to the enhanced growth of the market. Browse 400 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on “IV Equipment Market — Global Forecast to 2031” IV Equipment Market Size & Forecast: Market Size Available for Years: 2025–2031 2026 Market Size: USD 17.82 billion 2031 Projected Market Size: USD 23.92 billion CAGR (2026–2031): 6.1% IV Equipment Market Trends & Insights: The IV catheters segment accounted for the largest share of 37.0% of the market in 2025. The medication administration seg...